May 1, 2003
|
Effects of the Conjugate Vaccine on Invasive Pneumococcal Disease In 2000, a proteinpolysaccharide pneumococcal conjugate vaccine was recommended for use in infants and young children. Surveillance data show that from 1998 to 2001 the rate of invasive disease declined by 69 percent among children less than two years of age. There were also smaller but significant reductions in pneumococcal disease in adults. The use of the conjugate vaccine is reducing the frequency of pneumococcal sepsis and meningitis in infants and young children, for whom it is recommended. A side benefit appears to be the prevention of disease in adults because of reduced transmission of pneumococci from young children.
|
Effectiveness of Pneumococcal Vaccine in Older Adults This population-based, retrospective study of more than 47,000 older persons assessed the effectiveness of pneumococcal vaccination. Vaccination was associated with a significant reduction in the risk of pneumococcal bacteremia, but over three years of follow-up there was no reduction in the risk of community-acquired pneumonia (hazard ratio, 1.07). Although pneumococcal vaccination helps protect older persons against life-threatening bacteremia, it provides little if any protection against pneumonia. Other strategies are needed to prevent the nonbacteremic manifestations of pneumococcal infection.
|
|||||
|
Nitroprusside in Severe Aortic Stenosis and Heart Failure |
||||||
|
ZAP-70 Expression and Prognosis in Chronic Lymphocytic Leukemia |
||||||
|
Genomic Medicine: Hematologic Cancers Hematologic cancers that is, leukemias and lymphomas usually result from somatic mutations in hematopoietic cells rather than heritable mutations. Many of these cancers have been classified on the basis of their morphology and the presence of tumor marker antigens. This review explains complementary DNA expression profiling, a genomic approach to the diagnosis of such tumors, with certain leukemias and lymphomas used as examples.
|
Current Concepts: Management of Drug Withdrawal This review summarizes the current approaches to the management of withdrawal in patients addicted to sedatives such as alcohol or benzodiazepines, opioids, or stimulants such as amphetamines or cocaine. Included are details of detoxification regimens and guidelines for recognizing and managing the most common complications.
|
|||||
|
||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |